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Abstract
In 2009, a novel H1N1 Infl uenza virus has emerged and on June 11 the World Health Organization 
declared it as pandemic. It may cause acute respiratory failure ranging from severe Acute 
Respiratory Distress Syndrome to exacerbations of airfl ow limitation. Non-invasive ventilation is 
now considered fi rst-line intervention for different causes of acute respiratory failure and may 
be considered in the context of H1N1 pandemic. Although infection control issues have been 
arisen, non-invasive ventilation was effective and safe during the Severe Acute Respiratory 
Syndrome in Asia. It is reasonable to recommend non-invasive ventilation in H1N1-related 
exacerbations of chronic respiratory diseases, especially in negative-pressure wards. Treatment 
of early Acute Respiratory Distress Syndrome associated with H1N1 using non-invasive ventilation 
could be tried rapidly identifying those who fail without delaying endotracheal intubation. 
Considering the high demand for critical care beds during the pandemic, non-invasive ventilation 
may have a role in reducing the estimated load.
© 2010 Published by Elsevier España, S.L. on behalf of Sociedade Portuguesa de Pneumologia. 
All rights reserved.
Infecção pelo H1N1 e insufi ciência respiratória aguda: será que podemos 
dar a ventilação não-invasiva uma oportunidade?
Resumo
Em 2009, surgiu um novo vírus da gripe H1N1 e a 11 de Junho a Organização Mundial de Saúde 
declarou-o como uma pandemia. Poderá causar insuficiência respiratória, do Síndroma de 
Difi culdade Respiratória Agudo a manifestações de limitação do fl uxo de ar. A ventilação não 
invasiva é agora considerada como a primeira intervenção para diferentes causas de insufi ciência 
respiratória aguda e pode ser considerada no contexto da pandemia de H1N1. Apesar de terem 
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surgido problemas ligados ao controlo da infecção, a ventilação não invasiva foi efi caz e segura 
durante o Síndroma de Dificuldade Respiratória Agudo na Ásia. É razoável recomendar a 
ventilação não invasiva nas manifestações de doenças respiratórias crónicas ligadas ao H1N1, 
especialmente em serviços com pressão negativa. O tratamento do Síndroma de Difi culdade 
Respiratória Agudo precoce associado ao H1N1 utilizando ventilação não invasiva pode ser 
experimentado para identificar rapidamente aqueles que falham sem atrasar a intubação 
endotraqueal. Considerando a elevada procura de camas de cuidados intensivos, a ventilação 
não invasiva pode ajudar a reduzir a sobrelotação estimada.
© 2010 Publicado por Elsevier España, S.L. em nome da Sociedade Portuguesa de Pneumologia. 
Todos os direitos reservados.
Introduction
In April 2009 a new strain of human H1N1 infl uenza A virus 
was identifi ed in California. 1 As of November 15 it has caused 
526,060 cases worldwide and at least 6,770 deaths in more 
than 206 countries. 2
Influenza is normally a self-limited acute respiratory 
infection. However, the recent circulation of influenza 
A (H1N1) virus has been associated with severe disease 
and with excess pneumonia. 3 Data from Australia’s winter 
revealed a hospitalization rate of 23 per 100,000 population 
with 13 % of ICU admission. 4 The Canadian prospective study 
of critically ill patients with 2009 infl uenza (H1N1) infection 
revealed that major co-morbidities were present in only 
30,4 % of patients and was associated with severe hypoxemic 
respiratory failure. 5
Recent series from the US and Australia including critically 
ill patients with novel influenza A (H1N1) virus infection 
describe development of ARDS in 35.8 % and 48.8 % of cases 
and a 45 % and 14.3 % hospital mortality, respectively. 6,7 
Exacerbation of chronic diseases (Chronic Obstructive 
Pulmonary Disease-COPD- and chronic heart failure) occurs 
in 14.9 % of patients with H1N1 admitted to ICU in Utah 8 
and exacerbation of airfl ow limitation in 13.9 % of patients 
admitted to ICU in Australia and New Zealand. 7
The role of non-invasive ventilation 
in Acute Respiratory Failure
Since its initial reports in the late 1980s NIV has become 
a first-line intervention for different causes of acute 
respiratory failure (ARF). 9 It reduces intubation rate and 
mortality in ARF due to exacerbations of COPD 10 and acute 
cardiogenic pulmonary oedema. 11 However, data from 
surveys across the world suggests that NIV is still underused 
in some centres. 12
The role of NIV for hypoxemic respiratory failure is more 
controversial. However, it has been demonstrated in a 
randomized controlled trial that, with similar settings, NIV 
is equivalent to conventional ventilation in improving gas 
exchange with lower incidence of ventilator associated 
pneumonia. 13 According to a a large multicentric study, 
only 31 % of ARDS patients are eligible for NIV, but this 
intervention avoided intubation in around 50 % of cases; 14 
those with Simplified Acute Physiology Score ≤ 34 and 
PaO2/FIO2 > 175 after one hour were more likely to benefi t 
from NIV.
Non-invasive ventilation: the experience 
gained from Severe Acute Respiratory 
Syndrome
Severe Acute Respiratory Syndrome (SARS), due to a novel 
coronavirus, emerged in 2002, with signifi cant morbidity 
and mortality. Critically ill patients with SARS presented 
with Acute Lung Injury/ARDS in 82 % of cases, with 
mortality at 28 days of 45 %. 15 Those patients were at high 
risk of infecting health care workers (HCW), especially 
due to high-risk procedures coinciding with viral shedding 
peak. 16 Avoidance of non-invasive ventilation (NIV) and 
other aerosol-generating procedures were recommended 
in Canadian guidelines to minimise the occupational risk 
and nosocomial transmission. 17 However, this was due to a 
non-signifi cant increased risk from a retrospective ICU cohort 
analysis and others recommended NIV for respiratory distress 
and refractory hypoxemia in newly designed SARS wards. 18 In 
fact, NIV has been reported to be effective in SARS-related 
Acute Respiratory Failure without posing infection risks to 
HCW. 19 Yam LYC et al suggest that compared to invasive 
ventilation, NIV for ARF in SARS was associated with reduced 
mortality without any NIV-related SARS transmission within 
the 21 patients treated. 19 Moreover Cheung et al 20 in a 
retrospective analysis of 20 patients state that NIV (also 
performed in negative pressure rooms) avoided intubation 
in 70 % of cases and none of the 105 HCW caring for the 
patients acquired SARS. Another series in China reported 
the experience with NIV in 28 patients with SARS showing 
physiologic improvement and avoiding intubation in 67 % and 
none of the HCW contracted SARS. 21 In the US another report 
confi rms the lack of SARS transmission among 110 HCW with 
exposure to 6 SARS patients. 22
Non-invasive ventilation in H1N1 infection: 
the debate
Recently there has been some debate in literature about the 
use of NIV in the context of H1N1. 23 Should it be considered 
a high-risk procedure? Is it an effective ventilatory support 
in this scenario?
The concern of infectious droplet dispersion has 
been addressed by experimental models showing that 
exposure can occur within one metre of patients receiving 
Non-invasive Positive Pressure Ventilation. 24 However, it is 
questionable that a mannequin can confidently simulate 
NIV in real patients. Moreover wearing a face mask for NIV 
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can protect against particle generation during coughing and 
sneezing.
Due to the effi cacy previously described in SARS, NIV can 
be an attractive option especially in a pandemic scenario 
when the demand for critical care may be massive. 25
Non-invasive ventilation in H1N1 infection: 
the ongoing experience
Among the recently published major series of critically ill 
patients with novel infl uenza A (H1N1) virus infection, 5-8,26-28 
NIV has been reported in four of them, 5,26-28 including 
129 patients with a success ranging from 5 % to 100 % 
(table 1). Two smaller series 8,29 (in which NIV was tried 
in 21 patients) (table 2) and six case series (including 
10 patients) 30-35 describe success in 6 cases (20 %).
The majority were patients with severe ARDS in whom 
ventilatory support ranged from CPAP 33 to bi-level 
ventilation. 30 No mention of ventilatory parameters 27-29,31,32 
precludes some critical review of the negative results, but in 
the Spanish series Rello et al. 29 suggest that the Sequential 
Organ Failure Assessment score was higher in NIV failure. 
Moreover Estenssoro et al. 27 suggest that patients that used 
NIV were associated with a better outcome.
The impact of H1N1 infection on the southern hemisphere 
provided important lessons in critical care demand, 
revealing that in the epidemic peak in Australia and New 
Zealand the percentage of beds occupied by patients with 
H1N1 reached up to a maximum of 19 %. 7
In case ICU facilities cannot be expanded, NIV can be 
delivered in respiratory intermediate care units (RICU), 
offloading ICU beds. In fact during the H1N1 outbreak 
4 Mexican patients died while awaiting ICU beds. 26
From that previously described, approximately one-third 
of critically ill patients may be eligible for NIV. Moving from 
ventilatory support in the ICU to NIV in RICU may be crucial 
during H1N1 pandemic!
Novel infl uenza A (H1N1) virus infection 
among HCW: is there a cause for concern 
with non-invasive ventilation?
Nosocomial non-pandemic infl uenza outbreaks are usually 
underdetected and underreported but their consequences 
for hospitals in terms of morbidity and costs are 
considerable. 36
Soon after the identifi cation of novel infl uenza A (H1N1) 
virus infections in the US, 26 cases of infected HCW were 
reported by the CDC, 50 % of which were deemed to 
have acquired it in the health-care setting. 37 Although no 
mention of aerosol-generating procedures that put HCW at 
risk is made, the report highlighted the need to implement 
infection-control strategies to prevent transmission of novel 
H1N1 in hospitals. Of the 13 HCWs who were infected, 
only three had consistently used personal protective 
equipment. 37
Concerning the case of HCW transmission, in the recent 
series of critically ill H1N1 patients this has been stated 
only in 4, 3,5,26,29 ranging from zero in the Canadian series 5 
to 12 % in the Mexican study. 3 To be highlighted is the fact 
that in the latter report the authors verifi ed that no HCW 
were hospitalized after strict infection control measures 
were undertaken. 3 Since NIV is suggested as a risk factor 
for infection in hospital workers in these papers, although 
in some of the series there is omission of this information, it 
seems that the risk may not be so signifi cant after all!
Published recommendations for the use 
of non-invasive ventilation during 
H1N1 pandemic
Recently the European Respiratory Society and the European 
Society of Intensive Care Medicine released some guidelines 
on the use and limitations of NIV in patients with confi rmed 
H1N1 infection. 38 They suggest that NIV may be considered 
only in patients with mild to moderate hypercapnic acute 
respiratory failure, acute respiratory failure and/or distress 
due to cardiogenic pulmonary oedema, in the absence 
of pneumonia, multiple organ failure, and refractory 
hypoxemia.
The Australasian Society for Infectious Diseases (ASID) 
in a recent position statement also recommends that 
patients who require non-invasive ventilation should have 
priority for negative-pressure rooms if available. 39 This 
Table 1 Use of NIV in H1N1 2009 major critically-ill series
Author Kumar A Jain S Ugarte S Webb SA Dominguez-Cherit G Estenssoro E
Reference 5 6 28 7 26 27
N 168 67 75 722 58 337
Country Canada US Chile Australia/NZ Mexico Argentina
NIV use (N / %) 55(32.7 %) NR 4(7 %) NR 6 (10 %) 64 (19 %)
NIV success (N / %) 8(14.6 %) 4(100 %) ? 3 (5 %)
N-number of cases; % Percentage.
Table 2 Use of NIV in H1N1 2009 smaller critically-ill 
series
Author Miller RR Rello J
Reference 8 29
N 47 32
Country US Spain
NIV use (N / %) 13 (in 30 ARDS) 8 (33 %)
NIV success (N / %) 2 (15 %) 2 (25 %)
N-number of cases; % Percentage.
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has also been suggested by the UK Department of Health, 
which recommends use of a non-vented mask or helmet 
for NIV, a high-effi ciency bacterial/viral fi lter between the 
non-vented mask and the expiratory port and at the outlet 
of the ventilator. 40 In another NHS document developed 
in conjunction with the British Thoracic Society and the 
Intensive Care Society it is advised that NIV should be 
provided with strict safety measure for the HCW and by 
experienced teams. 41 It is proposed that NIV can have a role 
in influenza-related pneumonia as an early intervention, 
particularly in those with co-morbidities such as COPD. 
Moreover it can constitute ceiling to ventilator care in 
patients with COPD or heart failure with DNI orders.
From the previous discussion and current literature it 
is clear that if certain recommendations are followed NIV 
can be effective and safe in the context of H1N1 infection. 
Hence, we propose that we should give NIV a chance 
and suggest the management principles depicted in the 
table 3.
Conclusion
While the pandemic is still evolving across the globe we are 
deeply convinced that non-invasive ventilation can have a 
role in treating acute respiratory failure patients, reducing 
the need of ICU beds and improving outcomes.
Although there are some authors that reject NIV in 
infectious patients 43 the experience from recent series 
suggests that clinicians are using it even in countries 
where guidelines suggest its avoidance. 5 It is reasonable 
to recommend NIV in Chronic Heart Failure 35 and COPD 
with exacerbations attributable to H1N1, given the 
strong evidence of NIV in non-H1N1 patients with similar 
diseases. 10,11 For those patients with H1N1 associated ARDS 
a thorough selection is needed, although some may respond 
to NIV. 30 In this context NIV should be applied with specifi c 
resources by experienced teams.
To strengthen the position on non-invasive ventilation 
in the ongoing H1N1 pandemic infl uenza we encourage all 
clinicians to report their experience with this technique in 
this setting. Active surveillance of nosocomial infections is 
also highly recommended.
Early diagnosis and therapeutic interventions for severe 
H1N1 pandemic infl uenza should also be emphasized.
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